Prevention of Hemolytic Uremic Syndrome With Daily Bowel Lavage in Patients With Shiga Toxin-Producing Enterohemorrhagic Escherichia coli O104:H4 Infection
Infection with Shiga toxin-producing enterohemorrhagic Escherichia coli (EHEC) can cause hemorrhagic colitis and hemolytic uremic syndrome (HUS). 1 An epidemic outbreak of EHEC O104:H4 started in May 2011 in northern Germany, affecting 3842 patients and causing 855 cases of HUS. 2 There is little evidence in the literature that HUS can be effectively prevented.
In this case-series, we present our experience of daily intestinal lavage with polyethylene glycol (PEG) for prevention of HUS in an at-risk group of patients with EHEC. /L, multiply by 1), evidence of hemolytic anemia with hemoglobin level lower than 13 g/dL (to convert to g/L, multiply by 10) for male patients or lower than 12 g/dL for female patients, and acute renal insufficiency, defined as a 1.5-fold increase of serum creatinine level within 48 hours. The t test was used to compare interval variables after assuring that they met the assumptions of normality, and the Fisher exact test was used for comparing proportions.
Results | No significant difference was found between the control group and the treatment group regarding laboratory findings on admission (Table) . Hemolytic uremic syndrome developed in 8 of 12 patients (66%) in the control group vs 4 of 21 patients (19%) in the treatment group (P = .01).
Discussion | The 2011 German O104:H4 outbreak was characterized by a high rate of patients developing HUS. 3 To identify patients at risk of HUS development, we established risk criteria, reflecting the clinical symptoms and laboratory abnormalities of severe EHEC infection and indicating admission for further treatment. The admission procedure is shown in the Figure. Treatment of EHEC-associated bloody diarrhea is usually symptomatic and consists of adequate volume substitution. cytes returned to normal levels within the next 3 days. We believed it was likely that the PEG solution was effective by enhancing clearance of intestinal bacteria and toxins through dilution and large-volume lavage. On the basis of this theoretical rationale and our successful experience, we treated all subsequent patients with PEG solution lavage and found a lower rate of development of HUS compared with the control group.
Although all 33 patients tested positive for O104:H4 prior to hospitalization, stool cultures were not taken regularly following admission, so we cannot determine if patients in the treatment group had an accelerated clearance of EHEC bacteria. Also, we cannot rule out the possibility that the organism became less pathogenic over the time of the outbreak. Nonetheless, we believe that daily bowel lavage with PEG solution combined with intravenous rehydration is a promising treat- 2 The definition adopted for benign nodules was based on the assumption that no cancer was identified, when in fact it is unknown how many of these patients underwent fine-needle aspiration or surgery. Indeed, the degree of uncertainty regarding this aspect is crucial and somewhat worrying because all analyses presented were based on this assumption. Second, the size of the nodule is another aspect that deserves further discussion. In this context, a receiver operating characteristic curve analysis of the size of nodules would have added value to identify possible thresholds of size associated with increased risk of harboring a thyroid cancer. This is clinically relevant because recent reports observed that approximately 19% to 30% of patients with thyroid microcarcinoma may present a more aggressive tumor behavior with regional and distant metastasis. 3, 4 Finally, it would be interesting to present the posttest probability of each ultrasound imaging characteristic by using the Fagan nomogram. 5 By doing so, the unusual low pretest probability of thyroid cancer (1.6%) in this sample of patients with thyroid nodules would have been taken into consideration, providing better estimates of the clinical applicability of the studied ultrasonographic parameters.
